Retail sale of pharmaceutical products
RINGEN BANDAGIST AS
Revenue 2024
NOK 22.8m
Operating profit
NOK 1.3m
Equity
NOK 419,000
Incorporated
2010
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 22.8m | |
| Total operating costs | 21.6m | |
| Operating profit (EBIT) | 1.3m | |
| Net financial items | −20k | |
| Profit for the year | 968k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 4.3m | |
| of which current assets | 4.3m | |
| Equity | 419k | |
| Total liabilities | 3.9m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.